You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Merck
McKesson
Colorcon
Medtronic

Last Updated: April 10, 2021

DrugPatentWatch Database Preview

Litigation Details for Meijer, Inc. v. Bausch Health Companies Inc. (N.D. Cal. 2019)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Meijer, Inc. v. Bausch Health Companies Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Meijer, Inc. v. Bausch Health Companies Inc. (N.D. Cal. 2019)

Date Filed Document No. Description Snippet Link To Document
2019-09-18 1 Complaint 6,340,475 (‘475 patent) 9/16/2016 20 6,635,280 (‘280 patent) …Book patent (the ‘692 patent), as well as two non-Orange Book listed patents 20 (the ‘667 patent and…listed patent(s) and/or the patent is 2 invalid and unenforceable. Simply by listing the patents in the…and U.S. Patent No. 8,329,215 (“the ‘215 patent”)). 21 191. The ‘215 patent, like the ‘667…plaintiffs in the 8 patent lawsuit, Assertio/Santarus, to the defendant in the patent lawsuit, Lupin. Lupin External link to document
2020-03-04 188 Order on Motion to Dismiss four relevant patents: U.S. Patent Nos. 21 6,340,475; 6,635,280; 6,488,962… 16 for the patent barrier remains. New brand-drug applicants must list the patents (if any) covering…brand drug, that the relevant patents have expired, or that such patents are invalid or will not be …infringe the patents 4 because it designed around the patents using a… the patent suit, Lupin would stop challenging the 18 patent, and External link to document
2020-04-09 226 Amended Complaint Date Expiration Date 11 6,340,475 (’475 patent) March 29, 1999 January…Book patent (the ’692 patent) as well as two non- 28 Orange Book listed patents (the ’667 patent and…Assertio could not patent the drug itself. Instead, Assertio 13 obtained four patents covering extended-release…Lupin would infringe its patents. But Lupin had designed around Assertio’s patents; 6 indeed, before … would not infringe 7 Assertio’s patents and why the patents were invalid. 8 6. Sun External link to document
2020-08-15 347 Order on Motion to Certify Class four relevant patents: U.S. Patent Nos. 10 6,340,475; 6,635,280; 6,488,962…analogous anticompetitive behavior, patent misuse, by holding a patent …from an alleged reverse-payment settlement of a patent 17 infringement…restating. This case arises from a perversion of the patent and pharmaceutical- … 4 Patents covering the brand drug can still spoil the fun External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
Dow
AstraZeneca
Johnson and Johnson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.